Suppr超能文献

肝脏血管瘤的处理:外科治疗还是观察?

Management of hemangioma of the liver: surgical therapy or observation?

机构信息

Department of Surgery, University of Erlangen-Nuremberg, Krankenhausstr.12, 91054, Erlangen, Germany.

出版信息

World J Surg. 2013 Jun;37(6):1303-12. doi: 10.1007/s00268-013-1904-1.

Abstract

BACKGROUND

Elective surgery for liver hemangioma is controversial. We reviewed long-term outcomes following elective hepatectomy or observation only for symptomatic and asymptomatic liver hemangioma.

METHODS

All patients (n = 307) with liver hemangioma referred to our hospital for surgical evaluation from January 1988 to December 2009 were identified, and imaging results, tumor characteristics, surgical indication, surgical mode, outcome of observation, clinical and/or postoperative outcome, and adverse events were retrospectively evaluated.

RESULTS

Complete median follow-up for 246 patients was 124 months. Elective surgery was performed in 103 patients (symptomatic [n = 62] and asymptomatic [n = 41]). Postoperative morbidity occurred in 17 % of the patients and was significantly lower in asymptomatic patients (p = 0.002). No perioperative mortality was registered. Surgery relieved complaints in most (88 %) patients. In the observation group (n = 143), 56 % of patients had persistent or new onset of hemangioma-associated symptoms. Major hemangioma-related complications occurred in 12 patients (9 %) during the follow-up period, and 2 patients died after traumatic hemangioma rupture. Overall the rate of adverse events was by trend lower in the surgical group than in the observation group (35 versus 57 %; p = 0.08).

CONCLUSIONS

The majority of patients with liver hemangioma can be safely managed by clinical observation. In a subset of patients, especially those with giant hemangioma and/or occurrence of symptoms, surgical treatment could be considered and is justified in high-volume centers.

摘要

背景

择期手术治疗肝血管瘤存在争议。我们回顾了因症状性和无症状性肝血管瘤而行择期肝切除术或单纯观察的长期结果。

方法

我们确定了 1988 年 1 月至 2009 年 12 月期间因手术评估而被转诊至我院的所有(n=307)肝血管瘤患者,回顾性评估了影像学结果、肿瘤特征、手术适应证、手术方式、观察结果、临床和/或术后结果以及不良事件。

结果

246 例患者的中位随访时间为 124 个月。103 例患者(症状性[n=62]和无症状性[n=41])行择期手术。17%的患者发生术后并发症,无症状患者的并发症发生率明显较低(p=0.002)。无围手术期死亡病例。手术缓解了大多数(88%)患者的症状。在观察组(n=143)中,56%的患者出现持续性或新发的与血管瘤相关的症状。在随访期间,12 例(9%)患者发生重大血管瘤相关并发症,2 例患者因创伤性血管瘤破裂而死亡。总的来说,手术组的不良事件发生率低于观察组(35%比 57%;p=0.08)。

结论

大多数肝血管瘤患者可安全地进行临床观察。在某些患者中,尤其是那些存在巨大血管瘤和/或出现症状的患者,可考虑手术治疗,在高容量中心治疗是合理的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验